Reply to "GLP1RA versus SGLT2i tended to have more favorable ischemic outcomes including stroke?"

被引:0
|
作者
Hwang, In-Chang [1 ,2 ]
Kim, Chee Hae [3 ]
机构
[1] Seoul Natl Univ, Cardiovasc Ctr, Dept Internal Med, Bundang Hosp, Seongnam, Gyeonggi, South Korea
[2] Seoul Natl Univ, Div Cardiol, Bundang Hosp, Seongnam, Gyeonggi, South Korea
[3] Div Cardiol, Dept Internal Med, VHS Med Ctr, Seoul, South Korea
关键词
D O I
10.1016/j.ijcard.2022.08.047
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:12 / 12
页数:1
相关论文
共 50 条
  • [1] GLP1RA versus SGLT2i tended to have more favorable ischemic outcomes including stroke?
    Du, Lixin
    Zhang, Yu
    Wang, Pan
    Li, Zhigang
    Zhao, Yunhui
    Yuan, Jianpeng
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 366 : 31 - 31
  • [2] Trends in GLP1RA and SGLT2i Use in Ischemic Stroke Patients With Diabetes
    Yanus, Matthew R.
    Saleni, Angela
    Bhavsar, Riya
    Zhang, Tony
    McCane, Charles D.
    Pan, Alan P.
    Vahidy, Farhaan
    Gadhia, Rajan R.
    STROKE, 2024, 55
  • [3] Cardiovascular outcome with SGLT2i and GLP1RA
    Lim, Soo
    Sohn, Minji
    Nauck, Michael A.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 129 : 133 - 136
  • [4] Combined treatment with SGLT2i and GLP1ra compared with SGLT2i or GLP1ra alone improves survival: a Real-World Registry
    Garcia Vega, D.
    Cinza-Sanjurjo, S.
    Eiras, S.
    Gonzalez-Juanatey, J. R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 591 - 591
  • [5] GLP1RA Compared to SGLT2i Improves Depression Parameters in Veterans
    Jain, Arad
    Ubalde, Shannen Nicole
    Esper, Layal
    Powell, Joseph
    Meyer, Kristin
    Sen, Sabyasachi
    OBESITY, 2023, 31 : 87 - 88
  • [6] SGLT2i and GLP1RA effects in patients followed in a hospital diabetology consultation
    Lopes, Antonio Cabral
    Lourenco, Olga
    Morgado, Manuel
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2024, 17 (11) : 1081 - 1088
  • [7] Prevalence of SGLT2i and GLP1RA Use among US Adults with Type 2 Diabetes
    Limonte, Christine
    Hall, Yoshio
    Trikudanathan, Subbulaxmi
    Tuttle, Katherine R.
    Hirsch, Irl B.
    De Boer, Ian
    Zelnick, Leila
    DIABETES, 2022, 71
  • [8] Prevalence of SGLT2i and GLP1RA use among US adults with type 2 diabetes
    Limonte, Christine P.
    Hall, Yoshio N.
    Trikudanathan, Subbulaxmi
    Tuttle, Katherine R.
    Hirsch, Irl B.
    de Boer, Ian H.
    Zelnick, Leila R.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2022, 36 (06)
  • [9] Combined sodium-glucose-transporters inhibitors (SGLT2i) and glucagon-like-peptide receptor agonist (GLP1ra) compared with SGLT2i or GLP1ra alone improves survival: a Real-World Registry
    Vega, D. Garcia
    Cinza-Sanjurjo, S.
    Eiras, S.
    Gonzalez-Juanatey, J. R.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [10] Outcomes of Heart Failure with Preserved Ejection Fraction with GLP1RA plus SGLT2i vs SGLT2i alone: A Propensity-Matched Nationwide Cohort Study
    Almas, Talal
    Al-Kindi, Sadeer
    Akbar, Absam
    Qureshi, Amal
    Perez, Jaime Abraham
    Harper, Elleson Grace
    Syed, Saif
    Alazazzi, Hosam
    Sullivan, Claire
    Neeland, Ian
    Deshmukh, Abhishek
    Anavekar, Nandan
    CIRCULATION, 2024, 150